Evidence map›Paper›PMID 22210571›Full record

Trial reportDiabetes care2012

A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years.

Nelly Mauras, Roy Beck, Dongyuan Xing, Katrina Ruedy, Bruce Buckingham, Michael Tansey, Neil H White, Stuart A Weinzimer, William Tamborlane, Craig Kollman and 1 more

4 registry-linked trialsOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Diabetes care, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 87 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 6 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00760526 phase3completednot on this map

A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children (4 to <10 Year Olds)

TypeinterventionalSponsorJaeb Center for Health ResearchRan2010 to 2012Enrolled146ConditionsDiabetes Mellitus, Type 1ArmsContinuous glucose monitor, Home blood glucose monitor
NCT02912728 nacompletednot on this mapstarted 2017, after this paper: background citation

Strategies to Enhance New CGM Use in Early Childhood: A Randomized Clinical Trial to Assess the Efficacy and Safety of Continuous Glucose Monitoring in Youth < 8 With Type 1 Diabetes

TypeinterventionalSponsorJaeb Center for Health ResearchRan2017 to 2019Enrolled143ConditionsType 1 Diabetes MellitusArmsCGM + Family Behavioral Intervention, Standard CGM
NCT03199638 nacompletednot on this mapstarted 2016, after this paper: background citation

Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 Diabetes

TypeinterventionalSponsorNemours Children's ClinicRan2016 to 2017Enrolled14ConditionsDiabetes Mellitus, Type 1, Autoimmune Diseases, Diabetes Mellitus, Endocrine System DiseasesArmsGlutamine vs. Placebo, Exercise
NCT05107544 nacompletednot on this mapstarted 2021, after this paper: background citation

Metabolic, Physical Fitness and Mental Health Effects of High Intensity Interval Training (HIIT) in Adolescents With Type 1 Diabetes

TypeinterventionalSponsorHospital Las HiguerasRan2021 to 2022Enrolled30ConditionsDiabetes Mellitus, Type 1ArmsHIGH INTENSITY INTERVAL TRAINING
3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 6 syntheses or guidelines pooled it, 203 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Article
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Nelly MaurasDivision of Pediatric Endocrinology, Nemours Children's Clinic, Jacksonville, Florida, USA. direcnet@jaeb.org
Roy Beck
Dongyuan Xing
Katrina Ruedy
Bruce Buckingham
Michael Tansey
Neil H White
Stuart A Weinzimer
William Tamborlane
Craig Kollman
Diabetes Research in Children Network (DirecNet) Study Group
Jaeb Center for Health Research · USYale University · USNemours Children's Clinic · USStanford University · USUniversity of Iowa · USWashington University in St. Louis · US

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Spectrum Stanford Center for clinical and Translational Research and EducationUL1TR001085 · NCATS · STANFORD UNIVERSITY · PI CULLEN, MARK RICHARD, GREENBERG, HARRY BERNARD · 2013 to 2017
$37.1M
UNIVERSITY OF IOWA CTSA FOR PEDIATRIC RESEARCHUL1RR024979 · NCRR · UNIVERSITY OF IOWA · PI ROSENTHAL, GARY E · 2007 to 2011
$31.8M
Stanford Center for Clinical and Translational Education and Research (SCCTER)UL1UL1RR025744 · NCRR · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2008 to 2011
$22.4M
Cooperative Multicenter Diabetes Research Network for Hypoglycemia PreventionU10HD041890 · NICHD · JAEB CENTER FOR HEALTH RESEARCH, INC. · PI BECK, ROY W. · 2007 to 2011
$9.7M
Coordinating Center: Glucose Sensors in Type I DiabetesU01HD041890 · NICHD · JAEB CENTER FOR HEALTH RESEARCH, INC. · PI BECK, ROY W · 2001 to 2006
$4.1M
Yale Study of Closed-Loop Automated Glucose Control for Hypoglycemia PreventionU10HD041906 · NICHD · YALE UNIVERSITY · PI WEINZIMER, STUART ALAN · 2001 to 2011
$3.6M
Prevention of Nocturnal Hypoglycemia: Effect on Neurologic Outcome in ToddlersU10HD041908 · NICHD · STANFORD UNIVERSITY · PI BUCKINGHAM, BRUCE A · 2001 to 2011
$3.5M
Prevention of Hypoglycemia and Associated Complications in Type 1 DiabetesU10HD041915 · NICHD · UNIVERSITY OF IOWA · PI TSALIKIAN, EVA · 2001 to 2011
$3.4M
Hypoglycemia in Children and Adolescents with T1DM: Mechanisms and PreventionU10HD041918 · NICHD · NEMOURS CHILDREN'S CLINIC · PI MAURAS, NELLY · 2001 to 2011
$3.1M
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR001085NCRR NIH HHS UL1 RR024139NCRR NIH HHS UL1-RR-024139NCRR NIH HHS UL1 RR024979NCRR NIH HHS UL1-RR-024979NCRR NIH HHS UL1 RR024992NCRR NIH HHS UL1-RR-024992NCRR NIH HHS UL1 RR025744NCRR NIH HHS UL1-RR-025744NICHD NIH HHS HD-41890-10NICHD NIH HHS HD-41906-10NICHD NIH HHS HD-41908-10NICHD NIH HHS HD-41915NICHD NIH HHS HD-41918NICHD NIH HHS HD-56526NICHD NIH HHS U01 HD041890NICHD NIH HHS U10 HD041890NICHD NIH HHS U10 HD041906NICHD NIH HHS U10 HD041908NICHD NIH HHS U10 HD041915NICHD NIH HHS U10 HD041918NICHD NIH HHS U10 HD056526
6 · The paper itself

Abstract

objectiveContinuous glucose monitoring (CGM) has been demonstrated to improve glycemic control in adults with type 1 diabetes but less so in children. We designed a study to assess CGM benefit in young children aged 4 to 9 years with type 1 diabetes. RESEARCH DESIGN AND

methodsAfter a run-in phase, 146 children with type 1 diabetes (mean age 7.5 ± 1.7 years, 64% on pumps, median diabetes duration 3.5 years) were randomly assigned to CGM or to usual care. The primary outcome was reduction in HbA(1c) at 26 weeks by ≥0.5% without the occurrence of severe hypoglycemia.

resultsThe primary outcome was achieved by 19% in the CGM group and 28% in the control group (P = 0.17). Mean change in HbA(1c) was -0.1% in each group (P = 0.79). Severe hypoglycemia rates were similarly low in both groups. CGM wear decreased over time, with only 41% averaging at least 6 days/week at 26 weeks. There was no correlation between CGM use and change in HbA(1c) (r(s) = -0.09, P = 0.44). CGM wear was well tolerated, and parental satisfaction with CGM was high. However, parental fear of hypoglycemia was not reduced.

conclusionsCGM in 4- to 9-year-olds did not improve glycemic control despite a high degree of parental satisfaction with CGM. We postulate that this finding may be related in part to limited use of the CGM glucose data in day-to-day management and to an unremitting fear of hypoglycemia. Overcoming the barriers that prevent integration of these critical glucose data into day-to-day management remains a challenge.

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringChildChild, PreschoolDiabetes Mellitus, Type 1FemaleGlycated HemoglobinHumansHypoglycemic AgentsInsulinMaleBlood GlucoseGlycated HemoglobinHypoglycemic AgentsInsulin

Identifiers

PMID22210571
PMCPMC3263860
OpenAlexW2152979896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.